본문으로 건너뛰기
그룹별 보기 기록 1739건 · 페이지 32/35

사용금지 화장품 물질 — 부속서 II

부속서 II는 화장품 원료로 의도적으로 첨가하는 것이 금지된 물질을 나열합니다. 제17조는 별도로, 우수화장품제조관리기준(GMP)과 제3조의 안전 요건에 따라 기술적으로 피할 수 없는 비의도적 미량을 다룹니다. 이 페이지에는 기록 1739건이 있습니다.

이 부속서 필터링

이 부속서의 구성

Annex II is the prohibition list: 1,739 substances that may not be used in cosmetic products in the EU. Article 17 allows for traces that cannot be avoided — it does not allow for adding them.

  • 1,739 prohibited substances, 1,018 of them carrying a CMR classification.
  • Prohibition covers intentional addition; there is no permitted concentration.
  • Article 17 tolerates unintended traces only where they are technically unavoidable under good manufacturing practice and the product remains safe.
  • Absence from Annex II is not permission — most substances appear in no annex at all.

Annex II is the shortest kind of answer the regulation gives. A substance listed here may not be used as a cosmetic ingredient, and there is no concentration at which that changes. Where other annexes set limits and conditions, this one sets none, because there is nothing to condition.

The nuance people look for lives in Article 17 rather than in the annex. It provides that the unintended presence of a small quantity of a prohibited substance is permitted where it is technically unavoidable under good manufacturing practice and the product remains safe under Article 3. That is a provision about impurities and residues — what arrives with a raw material, what forms during manufacture, what migrates from packaging. It is not a tolerance to formulate against, and a deliberate addition at a low level is not covered by it.

Just over a thousand of these entries carry a CMR classification — carcinogenic, mutagenic or toxic for reproduction under the CLP Regulation. That is the route by which most of them arrived: Article 15 prohibits CMR substances in cosmetics, with a narrow derogation procedure that is rarely used, so a CLP classification generally becomes an Annex II entry in due course.

The most common misreading is the opposite of the list's own logic. A substance not found in Annex II has not been assessed and permitted. It has not been assessed at all. Most cosmetic ingredients appear in no annex, and their acceptability rests on the safety assessment the responsible person is required to hold.

대조 대상

부속서 II 기록

1739 총
이 목록의 기록, 총 1739건
항목물질CAS최대 농도표시
1578ParaformaldehydeCAS 30525-89-4 30525-89-4 —CMR
1579Methanediolmethylene glycolCAS 463-57-0 463-57-0 —
1580cymoxanil (ISO)2-cyano-N-[(ethylamino)carbonyl]-2-(methoxyimino)acetamide; [1]/ (2E)-2-cyano-N-[(ethylamino)carbonyl]-2-(methoxyimino)acetamide; [2]CAS 57966-95-7 / 166900-80-7 57966-95-7 / 166900-80-7 —CMR
1581Tributyltin compounds——CMR
1582Tembotrione (ISO)2-{2-chloro-4-(methylsulfonyl)-3-[(2,2,2-trifluoroethoxy)methyl]benzoyl}cyclohexane-1,3-dioneCAS 335104-84-2 335104-84-2 —CMR
15831,2-Benzenedicarboxylic acid, dihexyl ester, branched and linearCAS 68515-50-4 68515-50-4 —CMR
1584Spirotetramat (ISO)(5s,8s)-3-(2,5-dimethylphenyl)-8-methoxy-2-oxo-1-azaspiro[4,5]dec-3-en-4-yl ethyl carbonateCAS 203313-25-1 203313-25-1 —CMR
1585Dodemorph acetate4-cyclododecyl-2,6-dimethylmorpholin-4-ium acetateCAS 31717-87-0 31717-87-0 —CMR
1586Triflusulfuron-methylmethyl 2-({[4-(dimethylamino)-6-(2,2,2- trifluoroethoxy)-1,3,5-triazin-2- yl]carbamoyl}sulfamoyl)-3- methylbenzoateCAS 126535-15-7 126535-15-7 —CMR
1587Imazalil (ISO)1-[2-(allyloxy)-2-(2,4-dichlorophenyl)ethyl]-1H-imidazoleCAS 35554-44-0 35554-44-0 —CMR
1588Dodemorph (ISO)4-cyclododecyl-2,6-dimethylmorpholineCAS 1593-77-7 1593-77-7 —CMR
1589ImidazoleCAS 288-32-4 288-32-4 —CMR
1590Lenacil (ISO)3-cyclohexyl-6,7-dihydro-1H-cyclopenta[d]pyrimidine-2,4(3H,5H)-dioneCAS 2164-08-1 2164-08-1 —CMR
1591Metosulam (ISO)N-(2,6-dichloro-3-methylphenyl)-5,7-dimethoxy[1,2,4]triazolo[1,5-a]pyrimidine-2-sulfonamideCAS 139528-85-1 139528-85-1 —CMR
15922-Methyl-1-(4-methylthiophenyl)-2-morpholino-propan 1-oneCAS 71868-10-5 71868-10-5 —CMR
15932,3-Epoxypropyl methacrylateglycidyl methacrylateCAS 106-91-2 106-91-2 —CMR
1594Spiroxamine (ISO)8-tert-butyl-1,4-dioxaspirol[4.5]decan-2-ylmethyl(ethyl)(propyl)amineCAS 118134-30-8 118134-30-8 —CMR
1595CyanamidecarbanonitrilCAS 420-04-2 420-04-2 —CMR
1596Cyproconazole (ISO)(2RS,3RS; 2RS,3SR)-2-(4-chlorophenyl)-3-cyclopropyl-1-(1H-1,2,4-triazol-1-yl)butan-2-olCAS 94361-06-5 94361-06-5 —CMR
1597Silver zinc zeoliteCAS 130328-20-0 130328-20-0 —CMR
1598Cadmium carbonateCAS 513-78-0 513-78-0 —CMR
1599Cadmium hydroxidecadmium dihydroxideCAS 21041-95-2 21041-95-2 —CMR
1600Cadmium nitratecadmium dinitrateCAS 10325-94-7 10325-94-7 —CMR
1601Dibutyltin dilauratedibutyl[bis(dodecanoyloxy)] stannaneCAS 77-58-7 77-58-7 —CMR
1602Clorofenechlorophene; 2-benzyl-4-chlorophenolCAS 120-32-1 120-32-1 —CMR
1603Anthraquinone9,10-anthraquinoneCAS 84-65-1 84-65-1 —CMR
1604Nonadecafluorodecanoic acid [1]Ammonium nonadecafluorodecanoate [2]; Sodium nonadecafluorodecanoate [3]CAS 335-76-2[1] 3108-42-7[2] 3830-45-3[3] 335-76-2[1] 3108-42-7[2] 3830-45-3[3] —CMR
1605N,N'-MethylenedimorpholineN,N'-methylenebismorpholine; [formaldehyde released from N,N'-Methylenebismorpholine]; [MBM] if the maximum theoretical concentration of releasable formaldehyde, irrespective of the source, in the mixture as placed on the market is = 0,1 % w/wCAS 5625-90-1 5625-90-1 —CMR
1606Reaction products of paraformaldehyde with 2-hydroxypropylamine (3:2)[formaldehyde released from 3,3'-methylenebis[5–methyloxazolidine]; [formaldehyde released from oxazolidin]; [MBO] if the maximum theoretical concentration of releasable formaldehyde, irrespective of the source, in the mixture as placed on the market is = 0,1 % w/w——
1607Reaction products of paraformaldehyde with 2-hydroxypropylamine (1:1))[formaldehyde released from a,a,a-trimethyl-1,3,5-triazine-1,3,5(2H,4H,6H)-triethanol]; [HPT] if the maximum theoretical concentration of releasable formaldehyde, irrespective of the source, in the mixture as placed on the market is = 0,1 % w/w——
1608MethylhydrazineCAS 60-34-4 60-34-4 —CMR
1609Triadimenol (ISO)(1RS,2RS; 1RS,2SR)-1-(4-chlorophenoxy)-3,3-dimethyl-1-(1H-1,2,4-triazol-1-yl)butan-2-ol; a-tert-butyl-ß-(4-chlorophenoxy)-1H-1,2,4-triazole-1-ethanolCAS 55219-65-3 55219-65-3 —CMR
1610Thiacloprid (ISO)(Z)-3-(6-chloro-3-pyridyl-methyl)-1-3-thiazolidin-2-ylidenecyanamide; {(2Z)-3-[(6-chloropyridin-3-yl)methyl]-1,3-thiazolidin-2-ylidene}cyanamideCAS 111988-49-9 111988-49-9 —CMR
1611Carbetamide (ISO)(R)-1-(ethylcarbamoyl) ethyl-carbanilate; (2R)-1-(ethylamino) -1-oxopro-pan-2-yl-phenylcarbamateCAS 16118-49-3 16118-49-3 —CMR
1612Phosmet (ISO)S-[(1,3-dioxo-1,3-dihydro-2H- isoindol-2-yl)methyl]-O,O-dimethyl phosphorodithioate; O,O-dimethyl-S-phthalimidomethyl phosphorodithioateCAS 732-11-6 732-11-6 —CMR
1613Potassium permanganateCAS 7722-64-7 7722-64-7 —CMR
16142-Benzyl-2-dimethylamino-4'- morpholinobutyrophenoneCAS 119313-12-1 119313-12-1 —CMR
1615Quizalofop-p-tefuryl (ISO)(+/–) tetrahydrofurfuryl (R)-2-[4-(6- chloroquinoxalin-2-yloxy)phenyloxy]propionateCAS 200509-41-7 200509-41-7 —CMR
1616Propiconazole (ISO)(2RS,4RS; 2RS,4SR)-1-{[2-(2,4- dichlorophenyl)-4-propyl-1,3- dioxolan-2-yl]methyl}-1H- 1,2,4-triazoleCAS 60207-90-1 60207-90-1 —CMR
1617Pinoxaden (ISO)8-(2,6-diethyl-4-methylphenyl)-7-oxo-1,2,4,5-tetrahydro-7H-pyrazolo[1,2-d][1,4,5]oxadiazepin-9-yl 2,2-dimethylpropanoateCAS 243973-20-8 243973-20-8 —CMR
1618Tetramethrin(1-Cyclohexene-1,2-Dicarboximido)Methyl Chrysanthemate; 2,2-Dimethyl-3-(2-Methyl-1-Propenyl)Cyclopropanecarboxylic Acid (1,3,4,5,6,7-Hexahydro-1,3-Dioxo-2H-Isoindol-2-yl)Methyl EsterCAS 7696-12-0 7696-12-0 —CMR
1619(1,3,4,5,6,7-Hexahydro-1,3-dioxo-2H-isoindol-2-yl)methyl (1R-trans)-2,2-dimethyl-3-(2- methylprop-1-enyl)cyclopropanecarboxylateCAS 1166-46-7 1166-46-7 —CMR
1620Spirodiclofen (ISO)3-(2,4-dichlorophenyl)-2-oxo- 1-oxaspiro[4.5]dec-3-en-4-yl 2,2-dimethylbutyrateCAS 148477-71-8 148477-71-8 —CMR
1621Reaction mass of 1-[2-(2-aminobutoxy)ethoxy]but-2-ylamine and 1-({[2-(2-aminobutoxy)ethoxy]methyl}propoxy) but-2-ylamineCAS 897393-42-9 897393-42-9 —CMR
16221-VinylimidazoleCAS 1072-63-5 1072-63-5 —CMR
1623Amisulbrom (ISO)3-(3-bromo-6-fluoro-2-methylindol-1-ylsulfonyl)-N,N-dimethyl-1H-1,2,4-triazole-1-sulfonamideCAS 348635-87-0 348635-87-0 —CMR
1624Pirimicarb (ISO)2-(dimethylamino)-5,6-dimethylpyrimidin-4-yl dimethylcarbamateCAS 23103-98-2 23103-98-2 —CMR
16251,2-Dichloropropanepropylene dichlorideCAS 78-87-5 78-87-5 —CMR
1626Phenol, dodecyl-, branched [1]Phenol, 2-dodecyl-, branched [2]; Phenol, 3-dodecyl-, branched [3]; Phenol, 4-dodecyl-, branched [4]; Phenol, (tetrapropenyl) derivatives [5]CAS 121158-58-5[1]; 1801269-80-6[2] ; 1801269-77-1[3]; 210555-94-5[4]; 74499-35-7[5] 121158-58-5[1]; 1801269-80-6[2] ; 1801269-77-1[3]; 210555-94-5[4]; 74499-35-7[5] —
1627Coumatetralyl (ISO)4- hydroxy-3-(1,2,3,4-tetrahydro-1-naphthyl) coumarinCAS 5836-29-3 5836-29-3 —CMR

이 그룹별 보기 사용 방법

부속서 II에는 화장품에 사용이 금지된 물질이 포함되어 있습니다. 사용금지 물질 기록 1739건을 명칭, 식별자 및 연결된 항목 페이지별로 빠르게 훑어보려면 이 그룹별 보기를 이용하세요.

법적 문구 전문, 농도 논리, 경고 문구 또는 관련 식별자 링크가 필요하면 개별 기록을 여세요.